- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Nintedanib – March 2015
Nintedanib, 100 mg capsule, 60; 150 mg capsule, 60; Ofev®
Last updated
15 September 2015